@article{oai:shiga-med.repo.nii.ac.jp:00003998,
 author = {前平, 博充 and 飯田, 洋也 and 森, 治樹 and 新田, 信人 and 徳田, 彩 and 竹林, 克士 and 貝田, 佐知子 and 三宅, 亨 and 松原, 亜季子 and 谷, 眞至 and MAEHIRA, Hiromitsu and IIDA, Hiroya and MORI, Haruki and NITTA, Nobuhito and TOKUDA, Aya and TAKEBAYASHI, Katsushi and KAIDA, Sachiko and MIYAKE, Toru and MATSUBARA, Akiko and TANI, Masaji},
 journal = {Clinical journal of gastroenterology},
 month = {Oct},
 note = {Pancreatic acinar cell carcinoma is a rare tumor of the pancreas, and patients with such tumors rarely have a pathological complete response to treatment. Herein, we present a case involving a 48-year-old woman with a pancreatic tail mass. The pancreatic mass was connected to splenic and portal vein thrombosis. Distal pancreatectomy and removal of portal vein tumor thrombosis were performed. Ten months after surgery, multiple liver metastases and local recurrence in the pancreatic bed were detected, and chemotherapy was administered through the administration of a regimen containing both cisplatin and irinotecan. After seven courses of the cisplatin-plus-irinotecan regimen had been administered, computed tomography revealed that the patient had a partial response to treatment. Radical resection of multiple liver metastases and the locally recurrent tumor was performed. Pathological examination did not reveal the presence of carcinoma in any of the resected specimens. Thus, this case involves a pathological complete response in a patient with metastatic pancreatic acinar cell carcinoma who received a regimen containing both cisplatin and irinotecan. Our findings reveal that the administration of the cisplatin-plus-irinotecan regimen may be an option for the management of such tumors., Journal Article},
 title = {Pathological complete response in a patient with metastatic pancreatic acinar cell carcinoma who received a chemotherapy regimen containing cisplatin and irinotecan.},
 year = {2021}
}